KOMZIFTI® (ziftomenib) generated $9.1 million in net product revenue, up 57% over 1Q, and approximately 115 new patient starts, up 35% over 1Q ...

Overstory prevents a major cause of wildfires. But before the company could avert tragedy, it had to survive one of its own.

India has reportedly opened bidding for 60 military transport aircraft in a program valued at nearly Rs 1 lakh crore, or INR ...

The last time I spoke about Immunome, Inc. (IMNM), it was with a Seeking Alpha article entitled “Immunome: Maintaining 'Strong Buy' On Successful RINGSIDE Trial With Varegacestat.” With respect to ...

KOMZIFTI- (ziftomenib) generated $9.1 million in net product revenue, up 57% over 1Q, and approximately 115 new patient starts, up 35% over 1Q - - KOMZIFTI achieved majority share of new patient start ...

This important study demonstrates that nutrient resorption efficiency in the widespread wetland grass Phragmites australis is largely canalized by phylogeographic lineage, ecotype and geographic ...

Good day, and welcome to the Seer, Inc. Second Quarter 2026 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to ...

India AI data center deployment reaches a new frontier: L&T has secured a $1.05 to $1.57 billion contract to deploy 10,000 ...

Good morning, everyone, and thank you for joining us today as we review Harmony Biosciences' second quarter 2026 financial ...

Image source: The Motley Fool. Thursday, Aug. 6, 2026 at 4:30 p.m. ET Senior Vice President of Pharmaceutical Development-Ben ...

Enrollment in the ongoing Phase 1 dose escalation ACESOT-1051 trial of oral WEE1 inhibitor APR-1051 is accelerating as dose escalation ...

Bordetella pertussis hijacks the host innate immune protein PGLYRP1 via tracheal cytotoxin to suppress inflammation and evade killing, revealing a novel immune evasion strategy.